The Pharmaceutical Market: South Africa Opportunities and Challenges

Publisher Name :
Date: 08-Nov-2012
No. of pages: 103
Inquire Before Buying

OVERVIEW OF THE PHARMACEUTICAL MARKET IN SOUTH AFRICA

The government drive to support local production and reduce the country's reliance on imports, in addition to global epidemiological and demographic trends, are all positive factors contributing to long-term growth in the pharmaceutical market. However, deep segregation between private and public healthcare facilities continues to leave the vast majority of the population without medical care. BMI believes this will be rectified through the creation of the National Health Insurance scheme over the next decade, but in the meantime unemployment, lack of education and geographical inaccessibility to healthcare for the wider population will continue to hinder growth in the market.

Headline Expenditure Projections Pharmaceuticals: ZAR27.19bn (US$3.74bn) in 2011 to ZAR29.61bn (US$3.61bn) in 2012; +8.9% in local currency and -3.5% in US dollar terms. Healthcare: ZAR261.51bn (US$36.01bn) in 2011 to ZAR285.26bn (US$34.79bn) in 2012; +9.1% in local currency terms and -3.4% in US dollar terms. Medical devices: ZAR11.43bn (US$1.57bn) in 2011 to ZAR12.19bn (US$1.49bn) in 2012; +6.7% in local currency terms and -5.5% in US dollar terms. Forecast changed due to depreciation of the South African rand.

Product Description

The South Africa Pharmaceuticals & Healthcare Report features Espicom's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

Espicom's South Africa Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the South Africa pharmaceutical and healthcare industry.

Key Benefits


  • Benchmark Espicom's independent pharmaceutical and healthcare industry forecasts to test other views - a key input for successful budgeting and strategic business planning in the South Africa pharmaceutical and healthcare market.

  • Target business opportunities and risks in the pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in South Africa.

  • Assess the activities, strategy and market position of your competitors, partners and clients via our Company Profiles (inc. SWOTs, KPIs and latest activity) and Competitive Landscape Tables.


Executive Summary & Industry SWOT

An at-a-glance perspective on latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The SWOT outlines strategic factors which affect Espicom's forecast analysis, and taken together with Espicom's political, economic and business environment SWOTS, it gives a complete overview of market climate.

Market Summary
Snapshot of key market characteristics, including total size of pharmaceuticals and healthcare segments, growth drivers, leading therapeutic areas and the competitive landscape.

Regulatory Regime
Details of the industry regulatory framework and key legislation covering the licensing of new products/services, pricing and reimbursements, intellectual property, taxation and advertising, as well as an analysis of the overall regulatory burden.

Industry Developments
Focus on government healthcare reforms, epidemiological trends, company M&As, product launches, market entries, FDI activity, R&D, biotechnology, clinical trials and supply chain issues.

Espicom Industry Forecasts
Forecasts to end-2016 for all key industry indicators (see list below) supported by explicit assumptions, plus analysis of key downside risks to the main forecast, including:


  • Healthcare: Total healthcare expenditure (US$bn), healthcare expenditure (% of GDP), healthcare expenditure per capita (US$), hospital beds (per `000 population), doctors (per `000 population), birth and mortality rate (per `000 population)

  • Pharmaceutical market: Drug expenditure (US$bn), drug expenditure (% of GDP), drug expenditure per capita (US$)

  • Patented drug market: Prescription drug sales (US$bn), prescription sales (% of total sales), sales broken down by 14 therapeutic areas (cardiovascular, anti-infectives etc.)

  • Generic drug market: Generic product sales (US$bn), generic sales (% of total sales)

  • OTC drug market: OTC sales (US$bn), OTC sales (% of total sales), sales broken down by product types (analgesics, skin treatments, vitamins and minerals etc.)

  • Medical Devices: Medical device sales (US$bn), medical device sales (% of total healthcare market)

  • Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against US$, government expenditure, external debt.


Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Company Profiles

Examines the competitive positioning and short- to medium-term business strategies of key industry players. Strategy is examined within the context of Espicom's industry forecasts, our macroeconomic views and our understanding of the wider competitive landscape to generate Company SWOT analyses. The latest financial and operating statistics and key company developments are also incorporated within the company profiles, enabling a full evaluation of recent company performance and future growth prospects.

The Pharmaceutical Market: South Africa Opportunities and Challenges

EXECUTIVE SUMMARY... 1
Snapshot: Strategic Espicom Analysis.........2
Snapshot: Key Data Projections......3

MACROENVIRONMENT . 4

POLITICAL.....4

ECONOMIC...5
Projections...........5

LEGAL............6

DEMOGRAPHIC........7
Projections...........7
Latest Figures.......8
Demographic Indicators..9
Birth Rate... 9
Death Rate. 9
Infant MortalityRate (IMR) 9
Life Expectancy at Birth.... 9

EPIDEMIOLOGY............ 10

DISEASE BURDEN...10

DISEASE PREVALENCE........11
Communicable Diseases11
HIV/AIDS... 11
Malaria...... 11
TB.. 12
Non-Communicable Diseases....12
Cancer....... 12

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS.. 13

ORGANISATION......13
National Health Insurance..........13

EXPENDITURE.........14
Projections.........14
Latest Figures.....15

INFRASTRUCTURE..16
Hospital Infrastructure..16
Netcare Group ..... 17
Hospital Bed Provision...17

WORKFORCE...........18
Projections.........18
Physicians...........19
Public Workforce............19

REGULATORY AFFAIRS 20

NATIONAL AUTHORITY..... 20

MARKETING REGISTRATION.......... 20
National Procedures.......20

TRADE REGULATIONS ........21
Parallel Trade.....21

PRICING & REIMBURSEMENT... 22

NATIONAL AUTHORITY..... 22

PRICING...... 22
Dispensing Fees Charged by Pharmacists..........22

REIMBURSEMENT . 23
Essential Drugs List........23

DISTRIBUTION CHANNELS....... 24

DRUG RETAILING....24
Public Pharmacies............24
Private Pharmacies..........24
Pharmacy Trade Association......25
USAP.........25
Leading Pharmacy Chains..........25
Clicks.........25
Dischem...25
Medipost Courier Pharmacy.......25

MARKET ANALYSIS....... 26

SIZE 26
Projections.........26
Historical Figures............28
Current Structure............29
ARV Tender...........30

PRODUCT DEVELOPMENT 30

MANUFACTURING. 30

TRADE.........31
Exports..31
Imports..33
Balance of Trade38

COMPETITION.. 39

TRADE ASSOCIATION..........39

PIASA........39

COMPANY INTELLIGENCE. 40
Adcock Ingram.....40
Aspen Pharmacare...........40
Merck South Africa........... 41
Competitive Strategies..41
OTC PHARMACEUTICALS.......... 43

MARKET SIZE...........43

COMPETITION.........43
Trade Association...........43
SMASA......43

GENERIC PHARMACEUTICALS 44

MARKET SIZE.......... 44

COMPETITION........ 44
Trade Association...........44
NAPM........44
Company Intelligence....45
Aspen Pharmacare...........45
Cipla Medpro........45
Ranbaxy...45

BIOLOGICS & BIOSIMILARS......46

PRODUCT DEVELOPMENT 46
Lifelab.......46
TIA46

COMPETITION........ 46
Trade Association...........46
IMSA..........46
Company Intelligence....47
Arvir Technologies........... 47
Bioclones.. 47
Elevation Biotech. 47
iThemba Pharmaceuticals........... 47
Key Oncologics..... 47
National Bioproducts Institute... 47

CONCLUSIONS: OPPORTUNITIES & CHALLENGES.........48
Strategic Espicom Analysis............ 48
MACROENVIRONMENT...48
EPIDEMIOLOGY..48
HEALTHCARE......48
REGULATORY AFFAIRS....49
PRICING & REIMBURSEMENT......49
DISTRIBUTION CHANNELS..........50
MARKET.50
COMPETITION ....51
OTC PHARMACEUTICALS51
GENERIC PHARMACEUTICALS.....51
BIOLOGICS & BIOSIMILARS.........51
Radar Analysis........53
SWOT Analysis........53

DIRECTORY...... 54

COMPETITION........ 54
Pharmaceutical Companies........54
Generic Companies........54
Biologic Companies........54

GOVERNMENT ORGANISATIONS.. 54

PRODUCT DEVELOPMENT 54

TRADE ORGANISATIONS... 54

List of Tables
Espicom Analysis of the Pharmaceutical Market, 2012.. 2
Key Data Projections, 2011-2016.......... 3
Political Landscape, 2012........ 4
Regional Ranking of Projected Economies, 2016........... 5
Projected Economy, 2011-2016............ 5
Regional Ranking of Projected Demographics, 2016..... 7
Projected Demographics, 2011-2016... 7
Population by Gender & Province, 2011............ 8
Population by Gender & Age, 2011...... 8
Births, Deaths & Natural Increase, 1997-2010.. 9
Selected Causes of Death by Sex, 2007-2009.. 10
Estimated Number of Adults & Children Receiving ART, 2005-2010.......11
Reported Cases of Selected Communicble Diseases, 1990-201012
Regional Ranking of Projected Health Expenditure, 2016........ 14
Projected Health Expenditure, 2011-2016....... 14
Health Funding by Sector, 2007/08-2009/10 (Rand Millions)...15
Public Sector Hospitals by Province, 2004-2011........... 16
Private Sector Hospitals by Province, 2004-2010......... 16
Public Sector Hospital Beds by Province, 2005-2009....17
Private Sector Hospital Beds by Province, 1998-2010...17
Regional Ranking of Projected Physicians, 2016.......... 18
Projected Physicians, 2011-2016........ 18
Physicians by Province, 2009-2011.... 19
Public Physicians, Nurses, Dentists & Pharmacists, 2000-2011 19
Regional Ranking of Projected Pharmaceutical Markets, 2016 26
Projected Pharmaceutical Market at Retail Prices, 2011-2016.. 28
Historical Pharmaceutical Market at Retail Prices, 1995-2010. 28
Pharmaceutical Retail Sales by Month at Current Prices, 2005-2011 (R Millions) 29
Pharmaceutical Exports by Category, 1995-2010 (US$000s).... 31
Pharmaceutical Exports by Country/Region, 2010 (US$000s).. 32
Pharmaceutical Imports by Category, 1995-2010 (US$000s)... 33
Imports of Raw Materials by Country/Region, 2010 (US$000s)............ 35
Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s).... 36
Imports of Medicaments by Country/Region, 2010 (US$000s) 37
Balance of Pharmaceutical Trade, 1995-2010 (US$000s)......... 38
Member Companies of PIASA, 2011... 39
Member Companies of SMASA, 2011. 43
Member Companies of NAPM, 2011..44
Member Companies of IMSA, 2011....46
Espicom Analysis of the Pharmaceutical Market, 2012 52
SWOT Analysis of the Pharmaceutical Market, 2012... 53

List of Charts
Regional Comparison of Projected Pharmaceutical Markets at Retail Prices, 2016 27
Regional Comparison of Projected Pharmaceutical Market Share, 2016........... 27
Historical Pharmaceutical Market at Retail Prices, 1995-2010. 29
Pharmaceutical Exports, 1995-2010 (US$ Millions) .... 31
Pharmaceutical Imports, 1995-2010 (US$ Millions).... 33
Pharmaceutical Imports by Country/Region, 2010 (%)............ 34
Balance of Pharmaceutical Trade, 1995-2010 (US$ Millions)... 38
Radar Graph of the Pharmaceutical Market, 2012...... 53

  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Current State of Blood Banking Market, Products, Technologies and Services
    The global blood banking and blood products market is expected to reach US$41.9 billion by 2020 with USA continuing to be the largest market worldwide. Asia-Pacific follows a close second with a projected CAGR of 9.1% during this period owing to the refining healthcare infrastructure and increase in the per capita healthcare expenditure. The major [...]
  • United States Biomedical Metal Market Report 2021
    Published: 30-Aug-2016        Price: US 3800 Onwards        Pages: 105
    This report studies sales (consumption) of Biomedical Metal in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering - Zimmer Biomet - Dentsply - Invibio - Wright Medical Group N.V. - DSM Biomedical - Heraeus Medical Components - Carpenter Technology - ... Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divide......
  • 2016 Iodipamide (CAS 606-17-7) Industry Market Report
    Published: 30-Aug-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Iodipamide Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Iodipamide industry with a focus on the Chinese market. The report provides key statistics on the market status of the Iodipamide manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applicati......
  • 2016 Ioflupane (CAS 155798-07-5) Industry Market Report
    Published: 30-Aug-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Ioflupane Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Ioflupane industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ioflupane manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications......
  • Global Clinical Trials Imaging Market Research Report 2016
    Published: 30-Aug-2016        Price: US 2900 Onwards        Pages: 101
    Notes: Production, means the output of Clinical Trials Imaging Revenue, means the sales value of Clinical Trials Imaging This report studies Clinical Trials Imaging in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Bioclinica, Inc - Parexel International Corporation - Icon P......
  • 2016 Iophendylate (CAS 99-79-6) Industry Market Report
    Published: 30-Aug-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Iophendylate Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Iophendylate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Iophendylate manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, app......
  • 2016 Isoaminile (CAS 77-51-0) Industry Market Report
    Published: 30-Aug-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Isoaminile Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Isoaminile industry with a focus on the Chinese market. The report provides key statistics on the market status of the Isoaminile manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applicati......
  • United States Drugs for Warts Market Report 2021
    Published: 30-Aug-2016        Price: US 3800 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Drugs for Warts Revenue, means the sales value of Drugs for Warts This report studies sales (consumption) of Drugs for Warts in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering - Merck - Dr. Scholl's - DuoFilm - Rite Aid - Medigene - Hemispherx Biopharma - ... Split by product types, with sales, re......
  • 2016 Isocarboxazid (CAS 59-63-2) Industry Market Report
    Published: 30-Aug-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Isocarboxazid Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Isocarboxazid industry with a focus on the Chinese market. The report provides key statistics on the market status of the Isocarboxazid manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, ......
  • 2016 Isoetarine (CAS 530-08-5) Industry Market Report
    Published: 30-Aug-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Isoetarine Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Isoetarine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Isoetarine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applicati......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs